BioNTech

BioNTech SE is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases. It develops pharmaceutical candidates based on messenger RNA (mRNA) for use as individualized cancer immunotherapies, as vaccines against infectious diseases and as protein replacement therapies for rare diseases, and also engineered cell therapy, novel antibodies and small molecule immunomodulators as treatment options for cancer. The company developed an mRNA-based human therapeutic for intravenous administration to bring individualized mRNA-based cancer immunotherapy to clinical trials and to establish its own manufacturing process.


BioNTech SE is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases. It develops pharmaceutical candidates based on messenger RNA (mRNA) for use as individualized cancer immunotherapies, as vaccines against infectious diseases and as protein replacement therapies for rare diseases, and also engineered cell therapy, novel antibodies and small molecule immunomodulators as treatment options for cancer. The company developed an mRNA-based human therapeutic for intravenous administration to bring individualized mRNA-based cancer immunotherapy to clinical trials and to establish its own manufacturing process.
Read article on Wikipedia

BioNTech

BioNTech SE 被译为生物新技术公司,是德國一家生物技術公司,主要業務為开发和生产针对特定患者的治疗严重疾病的有效免疫疗法。


BioNTech SE 被译为生物新技术公司,是德國一家生物技術公司,主要業務為开发和生产针对特定患者的治疗严重疾病的有效免疫疗法。
Read article on Wikipedia

BioNTech

BioNTech is een biotechnologiebedrijf dat is gevestigd in Mainz.


BioNTech is een biotechnologiebedrijf dat is gevestigd in Mainz.
Read article on Wikipedia